Isabelle Opitz

🌍 @myESMO 2026 | Madrid, Spain

Inspiring days at #ESMO2026, with exciting developments for the #LungCancer community! 🔬

1/5 🧬 Major attention was drawn to DeLLphi-305, bringing promising news for patients with SCLC, alongside SAFFRON and OptiTROP-Lung06.

2/5 📊 The SARON trial showed improved progression-free survival in driver-negative oligometastatic NSCLC with radiotherapy (13.9 vs. 8.9 months), although no overall survival benefit was observed. Important findings presented by @fifimcdrmh

3/5 🔪 Exciting developments for the surgical community!
CTONG 1804 reported #conversion rates approaching 50%. @DoctorJSpicer presented findings from MDT-BRIDGE, highlighting the potential of ctDNA clearance as a predictor of pathological complete response (pCR) in resectable and borderline resectable NSCLC.
ctDNA clearance at C2D1 showed an 83.3% positive predictive value for pCR, providing valuable insights into treatment response.

4/5 🧬 De-escalation of immunotherapy in advanced or metastatic cancer was another key topic. While reducing treatment intensity may improve quality of life and minimise toxicity, further evidence is needed before routine implementation.

5/5 🎤 Delighted to contribute to the early-stage track alongside @MarianaBrandao0 , @stephanieplsaw , Jan von der Thüsen and Suresh Senan, discussing: “Multistation N2 (N2b), T4 lesions, and pneumonectomy: Time to reconsider induction chemo-immunotherapy?”

A valuable congress filled with scientific exchange, innovation and new perspectives for thoracic oncology!

#ESMO #ThoracicSurgery #LungCancer #Oncology #Immunotherapy #ClinicalTrials #USZ

🏆IASLC Cancer Care Team Award Europe🏆

What a special moment at the @IASLC #WCLC2026 in Seoul!

I am incredibly proud that our multidisciplinary team has been honoured with the @IASLC Cancer Care Team Award for Europe.

This recognition reflects what truly defines modern cancer care: close collaboration across disciplines and professions, combining different perspectives and expertise with one common goal - providing the best possible care for our patients.

I am very grateful to share this recognition with an outstanding team: @HillingerSven , Annegret Hinkelmann, Albana Rexhepaj, @raph_werner, @jonas_willmann, Laura Boos, Gian-Marco Monsch, @OliviaLauk, @SilviaUlrich6, Carolin Steinack, Andreas Wicki, Caroline Hertler, @UszDidi, Ömer Senbaklavaci, @Mat_Guc

This award belongs to the entire team and represents the dedication, trust and interdisciplinary collaboration that make comprehensive cancer care possible every day.

I am deeply grateful for this recognition and very proud of what we have achieved together.

#WCLC2026 #IASLC #CancerCareTeamAwardEurope #LungCancer #ThoracicOncology
#MultidisciplinaryCare #Teamwork #ThoracicSurgery

💙 Behind Every Successful Operation Is an Exceptional Team

Every successful operation relies on dedicated professionals working together to provide the best possible care for our patients.

Today, we would like to recognise our Operating Department Practitioners and especially thank Felix Jose Vega, Pili Vega and Bashkim Maksuti for their expertise, reliability and commitment to our team.

As Felix and Pili begin their well-deserved retirement, we would like to thank them for their many years of dedication and the important contribution they have made to @ThoracicZurich at the @Unispital_USZ . Your experience, support and positive spirit will certainly be missed.

And to Bashkim Maksuti: thank you for your continued dedication and for being such a valued part of our team.

Felix and Pili, we wish you all the very best for this new chapter, and above all, plenty of time to enjoy it! 💙

#ThoracicSurgery #OperatingRoom #Teamwork #PatientCare #Retirement #UniversityHospitalZurich #OperatingDepartmentPractitioner

🫁 New AATS Expert Consensus Document on N2+ NSCLC

It was a pleasure and great learning to contribute to the 2026 @AATSHQ Expert Consensus Document on the evaluation and management of N2+ non-small cell lung cancer (NSCLC) under the leadership of Philip Linden and Thomas D'Amico.

The management of N2-positive NSCLC remains one of the most complex areas in thoracic oncology!

This new consensus document provides updated recommendations on staging, patient selection and treatment strategies, highlighting the importance of multidisciplinary decision-making and close collaboration across specialties. 🤝🫁

Many thanks to the @AATSHQ and all colleagues involved in this collaborative effort.

Link to the paper: hubs.la/Q04rRCG50

#ThoracicSurgery #LungCancer #NSCLC #SurgicalOncology #MultimodalTherapy #AATS

🦾